78TH SCIENTIFIC SESSIONS PRODUCT THEATER SCHEDULE

 
NEXT SLIDES
78TH SCIENTIFIC SESSIONS PRODUCT THEATER SCHEDULE
Product Theaters, located within the Exhibit Hall, offer informative sessions focusing on products or a
single facet of diabetes. Product Theater sessions do not provide continuing education credit. These
sessions are intended for health care professionals only with practices relevant to the presented
information.
Light refreshments provided by the ADA will be served to the first 300 attendees.

SATURDAY, JUNE 23, 2018
10:15 a.m.-11:00 a.m.
Continuous Glucose Monitoring Reinvented—Introducing the FreeStyle Libre System
Presented by Abbott
Introducing the FreeStyle Libre System. Simple accurate,1 and more affordable* continuous glucose
monitoring for your patients.
1.FreeStyle Libre User’s Manual.
* Based on the manufacturer’s list price of the FreeStyle Libre system. The actual cost to you may or
may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
Presenters: W. Reid Litchfield, MD, FACE, ECNU, FRCP
            Desert Endocrinology
            Nevada Thyroid Institute
            Henderson, NV
               Featuring Mike Kelly
               NHL Assistant Coach, Vegas Golden Knights
               Pacific Division and Western Conference Champions
               Las Vegas, NV
     Location: Product Theater 1 (Booth 173)
10:15 a.m.-11:00 a.m.
Cardiovascular Disease Burden in the U.S. and Clinical Evaluation of VASCEPA® (Icosapent Ethyl)
Presented by Amarin Pharma, Inc.
Hear from an expert about cardiovascular disease burden in the U.S. and clinical evaluation of VASCEPA®
(icosapent ethyl). Despite the benefits of LDL-C lowering, many patients on statin therapy remain at risk.
In this presentation, new data and perspectives on the role of high triglycerides as a marker of increased
cardiovascular risk in patients with statin-controlled LDL-C will be discussed. The clinical development
program and safety for pure EPA VASCEPA® will be reviewed.
Presenter: Eliot A. Brinton, MD
           President
           Utah Lipid Center
           Salt Lake City, UT
Location:    Product Theater 2 (Booth 1472)

10:15 a.m.-11:00 a.m.
Introducing a New Era in Glucose Monitoring—The Eversense® Continuous Glucose Monitoring
System
Presented by Senseonics
The world’s first long-term implantable continuous glucose monitoring system.
Based on novel fluorescence technology, Eversense® provides continuous real-time readings up to 3
months with a single sensor. Get a first look at the product technology, which includes a wearable smart
transmitter that can be taken on or off and provides discreet vibratory glucose alerts. Learn about the
clinical performance resulting in sustained accuracy over the 3-month wear period. During this session,
you will hear from clinicians and patients discussing firsthand experience with the technology. At the
conclusion of the presentations, there will be a Q&A session. You don’t want to miss this panel of
industry experts and current Eversense® users!
Moderator: Steven Edelman, MD
           Division of Endocrinology and Metabolism
           University of California, San Diego
           Founder/Director
           Taking Care Of Your Diabetes (TCOYD)
           San Diego, CA
Presenters: Katherine Tweden, PhD
            Vice President, Clinical Sciences
            Senseonics, Inc.
            Germantown, MD
             Timothy S. Bailey, MD, FACE, FACP, CPI
             President and CEO
             AMCR Institute, Inc.
             Escondido, CA
             Jenine Yager Stone, MSN, FNP-C
             Assistant Director, Clinical Research
             AMCR Institute, Inc.
             Escondido, CA
             Tobias Schulte
             Eversense® User
Location:    Product Theater 3 (Booth 202)
12:15 p.m.-1:15 p.m.
Jardiance® (Empagliflozin) Tablets—Evolving Clinical Development
Presented by Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA
This program will discuss recent data from the ongoing Jardiance® clinical development program. The
presentation will cover efficacy and safety data, as well as the dosing information for Jardiance®.
Attendees will also have the opportunity to ask the faculty questions about the data presented.
Presenters: Leigh Perreault, MD
            Associate Professor of Medicine
            Division of Endocrinology, Metabolism, and Diabetes
            Affiliate Center for Global Health
            University of Colorado Anschutz Medical Campus
            Associate Professor of Epidemiology
            Colorado School of Public Health
            Boulder, CO
             Pam R. Taub, MD, FACC
             Associate Professor of Medicine
             University of California, San Diego Health System
             San Diego, CA
Location:    Product Theater 1 (Booth 173)

12:15 p.m.-1:15 p.m.
The Role of GLP-1 Receptor Agonist Therapy in Type 2 Diabetes Management
Presented by AstraZeneca Pharmaceuticals
This presentation will review the important role of glucagon-like peptide-1 (GLP-1) in physiologic glucose
regulation and the mechanism of GLP-1 receptor agonists in addressing the core defects of type 2
diabetes. The clinical efficacy, safety, and potential place in therapy of a once-weekly, GLP-1 receptor
agonist, prefilled autoinjector will be discussed. In addition, there will be a live demonstration of the
autoinjector.
Presenter: Robert S. Busch, MD
           Albany Medical College
           Albany, NY
Location:    Product Theater 2 (Booth 1472)

12:15 p.m.-1:15 p.m.
Developments in GLP-1 Treatment Options for Adults with Type 2 Diabetes
Presented by Novo Nordisk A/S
Presenter: James R. Gavin III, MD, PhD
           Clinical Professor of Medicine
           Emory University School of Medicine
           Chief Medical Officer
           Healing Our Village, Inc.
           Atlanta, GA
 Location: Product Theater 3 (Booth 202)
2:45 p.m.-3:30 p.m.
Evaluating the Impact of a Safety Outcomes Trial—Incidence of Major Adverse Cardiovascular Events
and Clinical Importance of Severe Hypoglycemia for Type 2 Diabetes Patients Requiring a Long-Acting
Insulin
Presented by Novo Nordisk A/S
Presenter: Helena W. Rodbard, MD, FACP, MACE
           Medical Director
           Endocrine and Metabolic Consultants
           Rockville, MD
Location:   Product Theater 2 (Booth 1472)

2:45 p.m.-3:30 p.m.
Introducing the New Dexcom G6—Simple, Accurate, Effective
Presented by Dexcom
Introduction and review of the new Dexcom G6 Continuous Glucose Monitoring System.
Dexcom G6 CGM technology features accuracy, usability, and product enhancement.
Dexcom G6 pivotal trial data, patient experience, and training best practices.
Presenters: Jake Leach
            Senior Vice President, Research and Development
            Dexcom
            San Diego, CA
            Keri Leone, MS, RD, CDE
            Senior Director, Global Professional Education
            Dexcom
            San Diego, CA
            R. Paul Wadwa, MD
            Associate Professor of Pediatrics
            University of Colorado School of Medicine
            Director of Telemedicine
            Medical Director, Pediatric Clinic,
            Barbara Davis Center for Childhood Diabetes
            Aurora, CO
 Location: Product Theater 3 (Booth 202)
SUNDAY, JUNE 24, 2018
10:15 a.m.-11:00 a.m.
Praluent® (Alirocumab) Injection—The Time to Treat Is Now
Presented by Sanofi-Regeneron
Presenter: Kenneth Feingold, MD
           Professor of Medicine
           University of California, San Francisco
           San Francisco, CA
 Location: Product Theater 1 (Booth 173)

10:15 a.m.-11:00 a.m.
Criticality of LDL-C Lowering in Patients with Diabetes Mellitus
Presented by Amgen
Presenter: Paul S. Jellinger, MD, MACE
           Professor of Clinical Medicine
           University of Miami Miller School of Medicine
           The Center for Diabetes and Endocrine Care
           Ft. Lauderdale, FL
 Location:   Product Theater 2 (Booth 1472)

10:15 a.m.-11:00 a.m.
The Guardian™ Connect Continuous Glucose Monitoring System—Utilizing Predictive Alerts and Data
Backed Insights to Help with Diabetes Management
Presented by Medtronic
Please join us and learn how predictive alerts and data backed insights of the Guardian™ Connect Smart
CGM system can help you and your patients with diabetes management. Presentation will include a
system overview, real-world data, case studies, and best practices.
Presenters: Timothy S. Bailey, MD, FACE, CPI
            President and CEO
            AMCR Institute, Inc.
            Clinical Associate Professor of Medicine
            University of California, San Diego
            Escondido, CA
             Huzefa Neemuchwala, PhD, MBA
             Senior Director, Data and Digital Information
             Medtronic Diabetes
             Northridge, CA
 Location:   Product Theater 3 (Booth 202)
12:30 p.m.-1:30 p.m.
Pneumococcal Disease in Adults Aged
3:00 p.m.-3:45 p.m.
Basal Insulin Treatment Considerations in Adult Patients with Type 2 Diabetes Mellitus
Presented by Sanofi
Presenter: Carol H. Wysham, MD
           Clinical Professor of Medicine
           University of Washington
           Spokane, WA
Location:   Product Theater 1 (Booth 173)

3:00 p.m.-3:45 p.m.
Closing the Loop with Blood Glucose Meters—Supporting Current Continuous Glucose Monitoring and
Future Therapies
Presented by Ascensia Diabetes Care
As diabetes management solutions continue to evolve, for all people with diabetes, the use of Blood
Glucose Meters (BGM) play an integral role in supporting other technologies such as Continuous Glucose
Monitors (CGM), Flash Glucose Monitors (FGM), Hybrid Closed-Loop System (HCLS) (such as the
Medtronic MiniMed™ 670G), and Artificial Pancreas Device Systems (APDS). This session will discuss
these technologies and the role of BGM within each.
Presenter: David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
           Clinical Professor of Medicine
           University of California, San Francisco
           Medical Director, Diabetes Research Institute
           Mills-Peninsula Medical Center
           San Francisco, CA
 Location: Product Theater 3 (Booth 202)
PRODUCT THEATERS
MONDAY, JUNE 25, 2018
10:15 a.m.-11:00 a.m.
MiniMed™ 670G System—Increasing Time In Range with Automated Insulin Delivery
Presented by Medtronic
Please join us and learn how the MiniMed™ 670G system has changed the way we are managing time in
range for patients with type 1 diabetes. Presentation will include real-world data, case studies, and best
practices.
Presenters: Jennifer Sherr, MD, PhD
            Pediatric Endocrinologist, Associate Professor
            Yale School of Medicine
            New Haven, CT
             Anders L. Carlson, MD
             Medical Director
             International Diabetes Center at Park Nicollet
             Minneapolis, MN
 Location:   Product Theater 1 (Booth 173)

10:15 a.m.-11:00 a.m.
Repatha® (Evolocumab)—Putting It into Practice
Presented by Amgen
Join Eliot A. Brinton, MD, FAHA, FNLA, as he conducts an educational presentation on the importance of
Repatha® (evolocumab). Hear about his experience with Repatha® and the options available for
appropriate patients.
Presenter: Eliot A. Brinton, MD, FAHA, FNLA
           President
           Utah Lipid Center
           Salt Lake City, UT
 Location: Product Theater 2 (Booth 1472)

DCT THEATERS
12:30 p.m.-1:30 p.m.
The Omnipod® DASH™ System—Simplifying Insulin Delivery for Your Patients and Practice
Presented by Insulet Corporation
Learn how the Omnipod® DASH™ Insulin Management System will build on the simplicity and ease-of-
use of the existing Omnipod® System platform leveraging its tubeless, waterproof design to address the
needs of people with insulin-dependent diabetes. The Omnipod® DASH™ System includes the Pod that
will remain unchanged in size with Bluetooth® technology for greater connectivity to the Personal
Diabetes Manager (PDM) as well as to the compatible Contour® NEXT One Blood Glucose (BG) Meter.
The new, slimmer PDM will feature a color touchscreen interface and will enable discreet insulin
delivery with a few finger taps. A new suite of iOS mobile applications will give users and
their caregivers quick and easy access to their insulin therapy information on their smartphones. The
Omnipod® DASH™ system will also be compatible with Insulet Provided Glooko for easy data upload,
improved care team collaboration, and access to meaningful data context which will allow for informed
diabetes management decisions. Come to our Product Theater to learn more about the Omnipod®
DASH™ System and Insulet’s commitment to reducing the burden of diabetes for health care providers,
users, and their caregivers. Caution: Pending 510(k) clearance. Not available for sale in the U.S.

Presenters: Trang Ly, MBBS, FRACP, PhD
            Senior Vice President and Medical Director
            Insulet Corporation
            Billerica, MA
             Daniel DeSalvo, MD
             Assistant Professor of Pediatrics of Diabetes & Endocrinology
             Baylor College of Medicine/Texas Children’s Hospital
             Houston, TX
 Location:   Product Theater 1 (Booth 173)

12:30 p.m.-1:30 p.m.
A Treatment Option for Adults with Type 2 Diabetes
Presented by Merck & Co., Inc.
Review select prescribing information for a type 2 diabetes therapeutic option.
Presenter: Lance Sloan, MD, FACE, FASN
           Private Practice
           Lufkin, TX
Location:    Product Theater 2 (Booth 1472)
You can also read
NEXT SLIDES ... Cancel